In contrast with previous studies, 3 Plewnia et al show only a temporary effect of rTMS on tinnitus, at least with currently used treatment schedules. The study also highlights the fact that blood flow asymmetries associated with tinnitus, and commonly used to target rTMS, can be quite variable among patients. In contrast with previous studies, which have focused on the primary auditory cortex, this study suggests that rTMS may attenuate tinnitus perception by influencing neural systems related to attention and emotion.
To individually adjust selection of the target area for rTMS, Plewnia et al used [
15 O]H 2 O positron emmision tomography before and after a lidocaine-induced reduction in tinnitus loudness to obtain each patient's maximum of tinnitusrelated cortical activity, as measured by regional cerebral blood flow (rCBF). A reduction in tinnitus after active rTMS correlated with change in rCBF in the anterior cingulate cortex immediately after the lidocaine injection. The temporoparietal cortex and the anterior cingulate cortex are known components of neural systems that mediate attention. 5 Interestingly, deficits in attention in people with tinnitus have been documented in the laboratory. 6 If rTMS is to be used clinically for the treatment of tinnitus, future studies must consider the following questions. Firstly, what schedule of rTMS can promote longterm change in tinnitus perception? Consecutive, week-long treatment schedules can ameliorate tinnitus in the short run, but booster sessions may be necessary as symptoms return to effect a long-term change. Secondly, do the asymmetries in rCBF observed in association with tinnitus change as tinnitus improves? Follow-up neuroimaging is necessary to learn whether these asymmetries are relevant and to validate models of tinnitus perception that concern cortical contributions.
